Showing results (871-880 of 386,331) with videos related to

Sort By:
Pageof 38,634
Angewandte Chemie (International Ed. in English)|September 13, 2023
Synthesis and Prospects of Holey Two-dimensional Platinum-group Metals in ElectrocatalysisSoumen Dutta, Byeong Su Gu, In Su Lee
Frontiers in Medicine|April 23, 2026
Prognostic analysis and development of a prognostic model for EML4-ALK-positive lung cancer patients treated with ALK-TKIsRuimin Liu, Chunrong Su, Hang Su, et al.
Genes|May 27, 2026
Histone Modifications: Decoding the Epigenetic Basis of Economic Traits in Livestock and PoultryYixin Su, Wenze Li, Qi Lv, et al.
Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry|August 16, 2022
A simple colorimetric method based on "on-off-on" mode for detection of H2S and Hg2+ in waterLixia Su, Xue Zhang, Yonghuan Su, et al.
Molecular and Cellular Biochemistry|August 8, 2026
GALNT6-glycosylated LRG1 mediates the interaction between M2 macrophages and pancreatic cancer cells by activating CCR1/PI3K/AKT axisDengjian Hong, Hang Su, Yexiong Su, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 17, 2021
Teleost-Specific MxG, a Traitor in the Mx Family, Negatively Regulates Antiviral Responses by Targeting IPS-1 for Proteasomal Degradation and STING for Lysosomal DegradationChengjian Fan, Hang Su, Zhiwei Liao, et al.
Oncology Research and Treatment|December 9, 2022
Pan-HER Tyrosine Kinase Inhibitor Pyrotinib Enhances Radiosensitivity via ERK1/2 Pathway in HER2-Positive Gastric CancerQian Niu, Jiamin Liu, Tingting Huang, et al.
Journal of Cancer|April 2, 2020
Anti-tumor Activity of Bufalin by Inhibiting c-MET Mediated MEK/ERK and PI3K/AKT Signaling Pathways in Gallbladder CancerLiqiang Qian, Haoyuan Su, Gang Wang, et al.
Frontiers in Pharmacology|May 6, 2022
Observation of Voriconazole in the Treatment of Liver Failure Complicated With Invasive Pulmonary Fungal Infection Induced by Chinese Patent Medicine in Teenagers: 2 Case ReportsQian Su, Jinjin Pan, Li Zhang, et al.
Frontiers in Oncology|June 1, 2022
Case Report: Radiotherapy Plus Immunotherapy and Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma With a Right Atrium and Inferior Vena Cava Tumor ThrombusYuting Qian, Long Gong, Su Li, et al.
Pageof 38,634